IP Library Granted Patent US 7,638,642
Granted Patent B2
US 7,638,642 · App. 11/572,404 · Granted Dec 29, 2009

Method for the preparation of D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative

Assignee: Hanmi Pharm, Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,638,642
App. No.
11/572,404
Granted
Dec 29, 2009
Kind
B2
Abstract

3R-carboxylate enantiomer derivative of formula (III) can be prepared easily and selectively by the method of the present invention, and a highly pure D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative can be prepared efficiently from the compound of formula (III) as an intermediate.

Claims (19)

1. A method for preparing a 2,2-difluoro-2-deoxy-1-oxoribose derivative of formula (I), comprising the steps of:

(i) reacting a compound of formula (V) with a biphenylcarbonyl derivative to obtain a compound of formula (IV) having the 3-hydroxy group protected by a biphenylcabonyl group;

(ii) reacting the compound of formula (IV) with a base in a mixed solvent essentially comprising water and isolating a resulting 3R-carboxylate enantiomer of formula (III) by filtration;

(iii) reacting the compound of formula (III) with an acid to obtain a 5-hydroxy-1-oxoribose derivative of formula (II); and

(iv) protecting the 5-hydroxy group of the compound of formula (II) with R 3 :

wherein,

R is

R 1 is methyl or ethyl;

R 2 C 1-3 alkyl;

r 3 is benzoyl or

R 4 is phenyl or substituted phenyl; and

M is sodium or potassium.

2. The method of claim 1 , wherein the biphenylcarbonyl group of step (i) is 2-biphenylcarbonyl or 4-biphenylcarbonyl.

3. The method of claim 1 , wherein the mixed solvent essentially comprising water used in step (ii) is a mixture of water and an organic solvent selected from the group consisting of tetrahydrofuran, dioxane, acetonitrile, acetone, methylisobutylketone, methylethylketone, methanol, ethanol, propanol, isopropanol, dimethylacetamide, dimethylformamide, dimethylsulfoxide, ethylacetate and a mixture thereof

4. The method of claim 1 , wherein the base used in step (ii) is selected from the group consisting of sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium carbonate, potassium bicarbonate, potassium hydroxide and a mixture thereof.

5. The method of claim 4 , wherein the base used in step (ii) is potassium carbonate.

6. The method of claim 1 , wherein the acid used in step (iii) is selected from the group consisting of 1 to 12 N HCl, 1 to 9 N H 2 SO 4 , methanesulfonic acid, p-toluenesulfonic acid, trifluoroacetic acid and trifluoromethanesulfonic acid.

7. The method of claim 6 , wherein the acid used in step (iii) is 12 N HCl.

8. The method of claim 1 , wherein the acid used in step (iii) is employed in an amount ranging from 1.1 to 1.5 equivalents based on the compound of formula (II).

Assignments (3)
CHANGE OF NAME Recorded Aug 3, 2012
From: HANMI HOLDINGS CO., LTD.
To: HANMI SCIENCE CO., LTD.
Reel/Frame 028722/0332 →
CHANGE OF NAME Recorded Jan 7, 2011
From: HANMI PHARM. CO., LTD.
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 025599/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2007
From: LEE, JAEHEON; PARK, GHA-SEUNG; LEE, MOONSUB; KIM, CHEOL-KYONG
To: HANMI PHARM. CO., LTD.
Reel/Frame 018810/0063 →
Priority Claims (1)
KR 10-2004-0057711 · Jul 23, 2004 · national
Continuity (1)
Related Publication 20080058509A1 · Mar 6, 2008